Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : SARS - what next? -- Ignore unavailable to you. Want to Upgrade?

To: Ilaine who wrote (349)	4/30/2003 8:12:55 AM
From: Ilaine	Respond to of 1070

Re: SARSblogs - DocBear's is my favorite - his country roundup using ordinary news sources like Reuters and reports on message boards by health care workers paints a less positive picture than WHO does. The statistics for Taiwan are really scary. South Korea is refusing to report to WHO that it has cases but South Korean newspaper says it does. agonist.got.net I also like SARSwatch, which also gives comprehensive in depth news. sarswatch.org The slice of life ones, like Dr. Jen Jen, are good because we all like the personal point of view. It seems like the feeding chain for SARS stories starts with rumor, moves to anecdote, then up the chain to newsgroup and blog and finally to mainstream news outlets.

To: Ilaine who wrote (349)	4/30/2003 8:21:47 AM
From: Ilaine	Respond to of 1070

Re: SARS and AIDS: >>This is an extremely important point. Yesterday's Washington Post (http://www.washingtonpost.com/wp-dyn/articles/A50579- 2003Apr28.html) described suggestions that infants and young children do not seem to be as severely affected by SARS. Do these stories have anything in common with suspicion that SARS may also be more severely impacting Asian countries? Distribution of a genetic polymorphism (variant R131/H131 to be specific) of the Fcgamma receptor (CD32) may have implications for disease susceptibility if cirulating IgG2 is involved. It turns out that the spike glycoprotein of some coronaviruses might in fact have such activity. The H131/R131 polymorphism is known to be an important outcome predictor in other diseases like bacterial respiratory infections, meningococcal infection, malaria, Dengue Hemorrhagic Fever, SLE, and Kaposi sarcoma. The H131 version has a high affinity for IgG2, while the R131 version of the receptor only binds IgG2 weakly. More importantly, the H131 version is present in 61% of ethnic Chinese, 50% of Japanese, while only 23% of Caucasians or Asian Indians have the high affinity H131 CD32 receptor. This suggests as a working hypothesis that SARS may provoke a cascade, via CD32-binding and downstream activation of NF-kB and other inflammatory pathways. Immune suppression could reduce the number of circulating CD32+ cells. Certainly infants have lower levels and activity of CD32+ cells, since it would be counterproductive to circulating maternal antibody levels.<< sarswatch.org